Opiant Pharmaceuticals, Inc. Debt to Equity Ratio 2014-2022 | OPNT
Current and historical debt to equity ratio values for Opiant Pharmaceuticals, Inc. (OPNT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Opiant Pharmaceuticals, Inc. debt/equity for the three months ending September 30, 2022 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2022-09-30 | $0.02B | $0.02B | 1.05 |
| 2022-06-30 | $0.02B | $0.03B | 0.65 |
| 2022-03-31 | $0.02B | $0.04B | 0.54 |
| 2021-12-31 | $0.02B | $0.05B | 0.50 |
| 2021-09-30 | $0.03B | $0.04B | 0.64 |
| 2021-06-30 | $0.03B | $0.04B | 0.70 |
| 2021-03-31 | $0.03B | $0.03B | 0.73 |
| 2020-12-31 | $0.03B | $0.04B | 0.71 |
| 2020-09-30 | $0.01B | $0.04B | 0.19 |
| 2020-06-30 | $0.01B | $0.03B | 0.15 |
| 2020-03-31 | $0.00B | $0.03B | 0.13 |
| 2019-12-31 | $0.01B | $0.03B | 0.17 |
| 2019-09-30 | $0.01B | $0.03B | 0.31 |
| 2019-06-30 | $0.01B | $0.02B | 0.44 |
| 2019-03-31 | $0.01B | $0.02B | 0.56 |
| 2018-12-31 | $0.01B | $0.02B | 0.74 |
| 2018-09-30 | $0.00B | $0.03B | 0.16 |
| 2018-06-30 | $0.01B | $0.01B | 0.77 |
| 2018-03-31 | $0.01B | $0.01B | 1.32 |
| 2017-12-31 | $0.01B | $0.01B | 0.60 |
| 2017-10-31 | $0.01B | $0.00B | 146.76 |
| 2017-09-30 | $0.00B | 0.00 | |
| 2017-07-31 | $0.01B | $0.00B | 1.49 |
| 2017-06-30 | $0.00B | 0.00 | |
| 2017-04-30 | $0.01B | $0.00B | 1.29 |
| 2017-03-31 | $0.00B | 0.00 | |
| 2017-01-31 | $0.01B | $0.01B | 1.18 |
| 2016-10-31 | $0.01B | $-0.01B | -1.39 |
| 2016-07-31 | $0.01B | $-0.01B | -1.40 |
| 2016-04-30 | $0.01B | $-0.00B | -1.66 |
| 2016-01-31 | $0.01B | $-0.01B | -1.27 |
| 2015-10-31 | $0.01B | $-0.01B | -1.05 |
| 2015-07-31 | $0.01B | $-0.01B | -1.06 |
| 2015-04-30 | $0.01B | $-0.01B | -1.21 |
| 2015-01-31 | $0.01B | $-0.01B | -1.19 |
| 2014-10-31 | $0.01B | $-0.00B | -1.47 |
| 2014-07-31 | $0.00B | $-0.00B | -1.10 |
| 2014-04-30 | $0.00B | 0.00 | |
| 2014-01-31 | $0.00B | 0.00 | |
| 2013-10-31 | $0.00B | 0.00 | |
